Replies to post #1888 on Lexington Biosciences Inc. (LXGTF)

[StockBro75]

The health implications for the USA populace are staggering. 50% of all heart attacks have no advanced warning because no one is measuring endothelial function. No one is measuring it because there is no easy method to do so at your general practitioner's office. LXGTF HeartSentry technology not only puts an easy method in the hands of your doctor, it puts it in the home consumers hands as well. Can you imagine what it could do for mortality rates if we could see 50% more of all heart attacks coming in advance and could take preventative action?

[Door2Door]

Add to that an increasingly aged populace and you have a perfect storm of market opportunity.